INTERNATIONAL PATENT: AMGEN INC. FILES APPLICATION FOR "EVALUATION OF MRNA TRANSCRIPT LEVELS USING DDPCR FOR EARLY POOL AND SINGLE-CELL CLONE ASSESSMENT IN CELL LINE DEVELOPMENT"

GENEVA, April 30 -- AMGEN INC. (One Amgen Center DriveThousand Oaks, California 91320-1799) filed a patent application (PCT/US2024/051847) for "EVALUATION OF MRNA TRANSCRIPT LEVELS USING DDPCR FOR EARLY POOL AND SINGLE-CELL CLONE ASSESSMENT IN CELL LINE DEVELOPMENT" on Oct 17, 2024. With publication no. WO/2025/085682, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZAH, Eugenia (One Amgen Center DriveLaw - Patent Operations MS 28-5-AThousand Oaks, California 91320-1799), COX, Kayley (One Amgen Center DriveLaw - Patent Op...